Market Cap:
$2.2T
0%
24h Vol:
$94.8B
0%
Dominance:
BTC 55.90%
0%
ETH 9%
0%

Live AVAX HAS NO CHILL (NOCHILL) vs Injective Quants (QUNT) Comparison

What would the price and market cap of AVAX HAS NO CHILL (NOCHILL) be if the market cap of AVAX HAS NO CHILL (NOCHILL) was equal to the market cap of Injective Quants (QUNT)?

Compare
$
Price of AVAX HAS NO CHILL if it had Injective Quants's market cap.
$00.75x

Difference between AVAX HAS NO CHILL (NOCHILL) and Injective Quants (QUNT)

NOCHILL Difference QUNT
Market Cap$459,1341.33x$345,518
Price$ 0.000296221.93x$ 0.0005711
Volume (24h)$50,62119.92x$2,541.14
FDV$459,1341.33x$345,518
Circulating Supply1,550,000,0002.56x604,886,557
Total Supply1,550,000,0002.56x604,886,557
% in Circulation100.00%1.00x100.00%
Max Supply1,550,000,0001.99x777,777,777
We're committed to your privacy. CryptoCalc uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

AVAX HAS NO CHILL or Injective Quants FAQ

Is AVAX HAS NO CHILL better than Injective Quants?

Choosing between AVAX HAS NO CHILL and Injective Quants depends on their tokenomics metrics, current market trends, your personal goals and how you plan to use cryptocurrency.

At the moment, AVAX HAS NO CHILL is priced at $ 0.00029622 with a market cap of $459,134, while Injective Quants trades around $ 0.0005711 with a market cap of $345,518. In most cases, cryptocurrencies with a lower market cap have higher upside and ROI potential.

To choose an asset that better suits your needs, it’s crucial to consider not only financial metrics but also the technology under cryptocurrency, utilities, community support, and developers' activity.Each has strengths in different areas, so it's best to consider what matters most to you when deciding.

Should I buy AVAX HAS NO CHILL or Injective Quants?

When deciding whether to buy AVAX HAS NO CHILL or Injective Quants, it's important to compare their current market positions and long-term potential.

Right now, AVAX HAS NO CHILL has a market cap of $459,134 and a daily trading volume of $50,621, while Injective Quants's market cap is $345,518 with $2,541.14 traded daily. Usually, a coin with lower market cap and higher trading volume has higher potential.

Also, you should consider factors like your risk tolerance, time horizon, and the evolving crypto landscape before making a decision. Research both projects carefully to see which one aligns better with your investment plans.

Should I invest in AVAX HAS NO CHILL or Injective Quants?

Choosing whether to invest in AVAX HAS NO CHILL or Injective Quants involves understanding their market positions and technological potential. While the latter requires more extensive research, market position can be analyzed based on stats like price, market cap, and FDV.

For example, AVAX HAS NO CHILL has a market cap of $459,134 with a price of $ 0.00029622 and FDV of $459,134, while Injective Quants has a market cap of $345,518, FDV of $345,518 and priced at $ 0.0005711. Coins with higher FDV and market cap are more “heavy” in terms of demonstrating wider positive price action. On the contrary, they are more liquid and less volatile, which is better for investing higher capital in them.

As with any investment, past performance does not guarantee future results, so it’s important to make decisions based on thorough research of fundamental factors as well.

What is the difference between AVAX HAS NO CHILL and Injective Quants?

The difference between AVAX HAS NO CHILL and Injective Quants lies primarily in their design and intended use.

At the same time, AVAX HAS NO CHILL holds a market cap of $459,134 with circulation supply of 1,550,000,000 and total supply of 1,550,000,000, while Injective Quants has a market cap of $345,518 with circulation supply of 604,886,557 and total supply of 604,886,557.

Each project offers unique advantages depending on what you're looking for — whether it's transaction speed, network security, smart contracts, or decentralization. Understanding these distinctions can help you decide which project aligns more closely with your interests.

AVAX HAS NO CHILL vs Injective Quants long term

Considering AVAX HAS NO CHILL vs Injective Quants for the long term requires examining their roadmaps, market trends, and adoption rates. Other factors that influence the development of any cryptocurrency are tokenomics metrics, the team behind a project, the amount of investments raised, and financial projections.

AVAX HAS NO CHILL currently has a market cap of $459,134, ATH of $ 0.03121838 at 2024-03-25 21:26, and holds market cap rank #3647 while Injective Quants has a market cap of $345,518, ATH of $ 0.0313927 at 2024-11-17 12:50, and holds market cap rank #3985. The rule is the following: the lower the market cap, FDV and market cap rank, the greater growth upside a coin has. However, higher market cap, FDV and market cap rank mean that a coin is more liquid, popular and secure as a store of value.

Future success could depend on technology updates, regulatory acceptance, and real-world use case growth. Long-term performance will likely be influenced by ecosystem expansion, developer activity, and macroeconomic factors.

LogoFollow usX SocialTelegram Social
Subscribe to our Newsletter
We're committed to your privacy. CryptoCalc uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.
© 2026 CryptoCalc. All rights reserved.